Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-14 4:19 pm Purchase | 2025-11-12 | 13D | Atara Biotherapeutics, Inc. ATRA | Redmile Group, LLC | 751,223 9.900% | 46,016 (+6.53%) | Filing History |
| 2025-11-14 4:15 pm Sale | 2025-09-30 | 13G | Zymeworks Inc. ZYME | Redmile Group, LLC | 3,705,750 4.900% | -444,877 (-10.72%) | Filing History |
| 2025-11-14 4:15 pm Sale | 2025-09-30 | 13G | Replimune Group, Inc. REPL | Redmile Group, LLC | 535,818 0.700% | -4,362,709 (-89.06%) | Filing History |
| 2025-08-26 5:01 pm Purchase | 2025-08-25 | 13D | Shattuck Labs, Inc. STTK | Redmile Group, LLC | 6,379,095 9.900% | 726,435 (+12.85%) | Filing History |
| 2025-08-15 5:01 pm Sale | 2025-08-14 | 13D | IGM Biosciences, Inc. IGMS | Redmile Group, LLC | 0 0.000% | -3,291,092 (Position Closed) | Filing History |
| 2025-08-14 4:20 pm Sale | 2025-06-30 | 13G | Zymeworks Inc. ZYME | Redmile Group, LLC | 4,150,627 5.600% | -689,836 (-14.25%) | Filing History |
| 2025-08-14 4:19 pm Sale | 2025-06-30 | 13G | Stoke Therapeutics, Inc. STOK | Redmile Group, LLC | 4,375,931 8.000% | -337,578 (-7.16%) | Filing History |
| 2025-08-14 4:18 pm Purchase | 2025-06-30 | 13G | REGENXBIO Inc. RGNX | Redmile Group, LLC | 5,062,477 9.900% | 120,165 (+2.43%) | Filing History |
| 2025-08-14 4:18 pm Purchase | 2025-06-30 | 13G | RAPT Therapeutics, Inc. RAPT | Redmile Group, LLC | 1,765,303 9.900% | 1,765,303 (New Position) | Filing History |
| 2025-08-14 4:17 pm Sale | 2025-06-30 | 13G | ALX Oncology Holdings Inc. ALXO | Redmile Group, LLC | 4,641,455 8.500% | -267,809 (-5.46%) | Filing History |
| 2025-08-14 4:15 pm Sale | 2025-06-30 | 13G | ADC Therapeutics S.A. ADCT | Redmile Group, LLC | 15,666,731 14.000% | -2,486 (-0.02%) | Filing History |
| 2025-08-06 9:00 pm Purchase | 2025-08-04 | 13D | Shattuck Labs, Inc. STTK | Redmile Group, LLC | 5,652,660 11.800% | 27,700 (+0.49%) | Filing History |
| 2025-07-03 4:01 pm Purchase | 2025-07-02 | 13D | Fate Therapeutics, Inc. FATE | Redmile Group, LLC | 17,941,579 14.900% | 124,945 (+0.70%) | Filing History |
| 2025-05-23 4:05 pm Purchase | 2025-05-16 | 13D | Atara Biotherapeutics, Inc. ATRA | Redmile Group, LLC | 705,207 9.900% | 103,964 (+17.29%) | Filing History |
| 2025-05-15 9:02 pm Sale | 2025-03-31 | 13G | Silence Therapeutics plc SLN | Redmile Group, LLC | 6,644,841 4.700% | -553,110 (-7.68%) | Filing History |
| 2025-05-15 9:01 pm Purchase | 2025-03-31 | 13G | Replimune Group, Inc. REPL | Redmile Group, LLC | 4,898,527 6.400% | 294,044 (+6.39%) | Filing History |
| 2025-05-15 9:01 pm Purchase | 2025-03-31 | 13G | Immunome, Inc. IMNM | Redmile Group, LLC | 5,361,187 6.200% | 471,633 (+9.65%) | Filing History |
| 2025-05-15 9:00 pm Purchase | 2025-03-31 | 13G | Atara Biotherapeutics, Inc. ATRA | Redmile Group, LLC | 601,243 9.900% | 601,243 (New Position) | Filing History |
| 2025-04-29 9:31 pm Purchase | 2025-04-25 | 13D | Absci Corporation ABSI | Redmile Group, LLC | 8,335,116 6.500% | 53,100 (+0.64%) | Filing History |
| 2025-02-14 8:04 pm Sale | 2024-12-31 | 13G | Zymeworks Inc. ZYME | Redmile Group, LLC | 4,840,463 7.000% | -261,448 (-5.12%) | Filing History |